Related Experiment Video
Updated: Aug 11, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity
W Hu1, C J Bellone, J J Baldassare
1Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract:
RhoA has been identified as an important regulator of cell proliferation. We recently showed that the Ras/RhoA pathway regulates the degradation of p27(Kip) and the progression of Chinese hamster embryo fibroblasts (IIC9 cells) through G1 into S phase (Weber, J. D., Hu, W., Jefcoat, S. C., Raben, D. M., and Baldassare, J. J. (1997) J. Biol. Chem. 272, 32966-32971). In this report, we have demonstrated that, in IIC9 cells, RhoA regulates cyclin E/CDK2 activity, which is required for p27(Kip) degradation. As previously shown in several fibroblasts cell lines, expression of dominant-negative CDK2 in IIC9 cells blocked serum-induced cyclin E/CDK2 activity and p27(Kip) degradation. In the absence of serum, expression of constitutively active RhoA(63) resulted in significant stimulation of cyclin E/CDK2 activity and degradation of p27(Kip). Cotransfection of dominant-negative CDK2 and RhoA(63) inhibited RhoA(63)-induced cyclin E/CDK2 activity and p27(Kip) degradation. In addition, expression of dominant-negative RhoA blocked serum-induced cyclin E/CDK2 activity and p27(Kip) degradation. Finally, expression of catalytically active cyclin E/CDK2 rescued the effect of expression of dominant-negative RhoA. Taken together, these data show that RhoA regulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity.
Insights
RhoA regulates cell cycle progression by controlling cyclin E/CDK2 activity, which is essential for p27(Kip) degradation. This pathway is key for cell proliferation in fibroblasts.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- RhoA is a key regulator of cell proliferation.
- The Ras/RhoA pathway influences p27(Kip) degradation and cell cycle progression from G1 to S phase.
Purpose of the Study:
- To investigate the role of RhoA in regulating cyclin E/CDK2 activity and p27(Kip) degradation in Chinese hamster embryo fibroblasts (IIC9 cells).
Main Methods:
- Utilized dominant-negative CDK2 and constitutively active RhoA(63) expression in IIC9 cells.
- Assessed the impact of RhoA and CDK2 manipulation on cyclin E/CDK2 activity and p27(Kip) degradation.
- Employed cotransfection and rescue experiments with catalytically active cyclin E/CDK2.
Main Results:
- RhoA regulates cyclin E/CDK2 activity, which is necessary for p27(Kip) degradation.
- Dominant-negative CDK2 inhibited serum-induced cyclin E/CDK2 activity and p27(Kip) degradation.
- Constitutively active RhoA(63) stimulated cyclin E/CDK2 activity and p27(Kip) degradation in the absence of serum.
- Dominant-negative RhoA blocked serum-induced cyclin E/CDK2 activity and p27(Kip) degradation.
Conclusions:
- RhoA acts upstream of cyclin E/CDK2 to regulate p27(Kip) degradation.
- The RhoA/cyclin E/CDK2 pathway is a critical mechanism controlling cell cycle progression.
Related Concept Videos
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Anaphase Promoting Complex
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Inhibition of CDK Activity

